JP2019522626A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019522626A5 JP2019522626A5 JP2018557105A JP2018557105A JP2019522626A5 JP 2019522626 A5 JP2019522626 A5 JP 2019522626A5 JP 2018557105 A JP2018557105 A JP 2018557105A JP 2018557105 A JP2018557105 A JP 2018557105A JP 2019522626 A5 JP2019522626 A5 JP 2019522626A5
- Authority
- JP
- Japan
- Prior art keywords
- hiv
- protein
- modified
- vaccine composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662330604P | 2016-05-02 | 2016-05-02 | |
| US62/330,604 | 2016-05-02 | ||
| PCT/US2017/030375 WO2017192434A1 (en) | 2016-05-02 | 2017-05-01 | Compositions and methods related to hiv-1 immunogens |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019522626A JP2019522626A (ja) | 2019-08-15 |
| JP2019522626A5 true JP2019522626A5 (https=) | 2020-02-06 |
| JP7046832B2 JP7046832B2 (ja) | 2022-04-04 |
Family
ID=60203504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018557105A Active JP7046832B2 (ja) | 2016-05-02 | 2017-05-01 | Ｈｉｖ－１免疫原に関連した組成物および方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (5) | US10647748B2 (https=) |
| EP (1) | EP3452494A4 (https=) |
| JP (1) | JP7046832B2 (https=) |
| CN (1) | CN109153704A (https=) |
| AU (2) | AU2017259275C1 (https=) |
| BR (1) | BR112018072248A2 (https=) |
| CA (1) | CA3022826A1 (https=) |
| EA (1) | EA201892233A1 (https=) |
| IL (2) | IL299962A (https=) |
| MX (1) | MX2018013455A (https=) |
| SG (1) | SG11201809387QA (https=) |
| WO (1) | WO2017192434A1 (https=) |
| ZA (1) | ZA201807216B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11572389B2 (en) * | 2017-01-27 | 2023-02-07 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Vaccine compositions of herpesvirus envelope protein combinations to induce immune response |
| CN112469661B (zh) * | 2018-06-13 | 2024-04-26 | 斯克里普斯研究学院 | 具有新结构组分的纳米粒疫苗 |
| WO2020117760A1 (en) * | 2018-12-03 | 2020-06-11 | Duke University | Purification method for recombinant proteins and nanoparticles |
| AU2020323462A1 (en) * | 2019-07-26 | 2022-03-10 | The Scripps Research Institute | Engineered HCV E2 immunogens and related vaccine compositions |
| EP4051318A4 (en) * | 2019-10-29 | 2023-10-11 | International AIDS Vaccine Initiative | ENGINEERED ANTI-ENV HIV ANTIBODIES |
| JP7170942B1 (ja) * | 2019-11-07 | 2022-11-14 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | タンパク質精製 |
| CN111647078B (zh) * | 2020-06-22 | 2022-04-26 | 中国医学科学院医学生物学研究所 | 一种抗hiv的单克隆抗体及其制备方法和应用 |
| US10906944B2 (en) | 2020-06-29 | 2021-02-02 | The Scripps Research Institute | Stabilized coronavirus spike (S) protein immunogens and related vaccines |
| WO2022100703A1 (zh) * | 2020-11-12 | 2022-05-19 | 厦门大学 | 经改造的人免疫缺陷病毒膜蛋白及其应用 |
| CN116769053B (zh) * | 2023-05-26 | 2023-12-15 | 华中农业大学 | 重组AaLS-BPP融合肽、制备方法及应用 |
| CN121293297A (zh) * | 2025-12-04 | 2026-01-09 | 广州千扬生物医药技术有限公司 | 一种hiv纳米颗粒疫苗 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU698962B2 (en) | 1993-09-14 | 1998-11-12 | Epimmune, Inc. | Alteration of immune response using pan DR-binding peptides |
| US7550143B2 (en) | 2005-04-06 | 2009-06-23 | Ibc Pharmaceuticals, Inc. | Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| WO2008063331A2 (en) * | 2006-10-23 | 2008-05-29 | Progenics Pharmaceuticals, Inc. | Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric complexes, and uses thereof |
| JP2011502521A (ja) * | 2007-11-12 | 2011-01-27 | ザ ヘンリー エム． ジャクソン ファウンデーション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド | Ｈｉｖ−１外被糖タンパク質オリゴマー及び使用方法 |
| RU2540871C2 (ru) | 2008-02-01 | 2015-02-10 | Альфа-О Пептидес Аг | Самоорганизующиеся пептидные наночастицы, полезные в качестве вакцин |
| EP2765138B1 (en) * | 2012-11-05 | 2018-01-10 | International Aids Vaccine Initiative | HIV-1 envelope glycoprotein |
| AP2015008634A0 (en) | 2013-01-07 | 2015-07-31 | Beth Israel Hospital | Stabilized human immunodeficiency virus 'hiv' env elope 'env' trimer vaccines and methods of using same |
| WO2016037154A1 (en) * | 2014-09-04 | 2016-03-10 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Recombinant hiv-1 envelope proteins and their use |
| US10501733B2 (en) | 2015-02-27 | 2019-12-10 | University Of Washington | Polypeptide assemblies and methods for the production thereof |
| AR109528A1 (es) * | 2016-09-15 | 2018-12-19 | Janssen Vaccines & Prevention Bv | Mutaciones estabilizantes de trímeros de proteínas de la envoltura del vih |
-
2017
- 2017-05-01 SG SG11201809387QA patent/SG11201809387QA/en unknown
- 2017-05-01 IL IL299962A patent/IL299962A/en unknown
- 2017-05-01 CA CA3022826A patent/CA3022826A1/en active Pending
- 2017-05-01 CN CN201780027483.6A patent/CN109153704A/zh active Pending
- 2017-05-01 MX MX2018013455A patent/MX2018013455A/es unknown
- 2017-05-01 BR BR112018072248-0A patent/BR112018072248A2/pt active IP Right Grant
- 2017-05-01 WO PCT/US2017/030375 patent/WO2017192434A1/en not_active Ceased
- 2017-05-01 AU AU2017259275A patent/AU2017259275C1/en active Active
- 2017-05-01 EA EA201892233A patent/EA201892233A1/ru unknown
- 2017-05-01 EP EP17793064.1A patent/EP3452494A4/en active Pending
- 2017-05-01 JP JP2018557105A patent/JP7046832B2/ja active Active
-
2018
- 2018-10-24 IL IL262582A patent/IL262582B2/en unknown
- 2018-10-29 ZA ZA2018/07216A patent/ZA201807216B/en unknown
- 2018-10-31 US US16/176,200 patent/US10647748B2/en active Active
-
2020
- 2020-02-03 US US16/780,495 patent/US11236134B2/en active Active
-
2021
- 2021-08-25 AU AU2021221582A patent/AU2021221582B2/en active Active
- 2021-12-16 US US17/553,070 patent/US11767347B2/en active Active
-
2023
- 2023-08-15 US US18/449,739 patent/US20240083954A1/en not_active Abandoned
-
2024
- 2024-08-28 US US18/817,389 patent/US20250122247A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019522626A5 (https=) | ||
| JP7250878B2 (ja) | 新規多価ナノ粒子に基づくワクチン | |
| AU2019285048B2 (en) | Nanoparticle vaccines with novel structural components | |
| JP2021527077A5 (https=) | ||
| JP2021502807A5 (https=) | ||
| US10906943B2 (en) | Virus-like particles with high-density coating for inducing the expression of antibodies | |
| IL274130B2 (en) | Novel scaffolded hiv-1 vaccine immunogens | |
| US10577398B2 (en) | Multimerization of recombinant protein by fusion to a sequence from lamprey | |
| CN107344969B (zh) | 一种纳米流感疫苗及构建方法和应用 | |
| Yong et al. | Development of virus‐like particles‐based vaccines against coronaviruses | |
| HK1245809A1 (en) | Multimerization of recombinant protein by fusion to a sequence from lamprey | |
| JP2020509770A5 (https=) | ||
| CA3040418A1 (en) | Production of soluble hiv envelope trimers in planta | |
| US20240189407A1 (en) | Modified virus-like particles of bacteriophage ap205 | |
| US11535651B2 (en) | Hepatitis B nanoparticle-based vaccine for influenza virus |